B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies

被引:35
|
作者
Zhan, Yan [1 ,2 ,3 ,4 ,5 ]
Yin, Hui [1 ,2 ,3 ,4 ,5 ]
Yin, Ji-Ye [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410078, Peoples R China
[2] Cent South Univ, Inst Clin Pharmacol, Changsha 410078, Peoples R China
[3] Hunan Key Lab Pharmacogenet, Changsha 410078, Peoples R China
[4] Engn Res Ctr Appl Technol Pharmacogen, Minist Educ, 110 Xiangya Rd, Changsha 410078, Peoples R China
[5] Natl Clin Res Ctr Geriatr Disorders, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China
[6] Hunan Key Lab Precise Diag & Treatment Gastrointe, Changsha 410078, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Key words; COVID-19; B; 1; 617; 2; Delta variants; SARS-CoV-2; transmission; vaccines; diagnosis; structural biology; immune; escape; VACCINE; EMERGENCE; B.1.1.7; SPIKE;
D O I
10.7150/ijbs.66881
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic. With the continuous evolution of the viral genome, SARS-CoV-2 has evolved many variants. B.1.617.2, also called Delta, is one of the most concerned variants. The Delta variant was first reported in India at the end of 2020 but has spread globally, by now, to 135 countries and is not stand still. Delta shared some mutations with other variants, and owned its special mutations on spike proteins, which may be responsible for its strong transmission and increasing virulence. Under these circumstances, a systematic summary of Delta is necessary. This review will focus on the Delta variant. We will describe all the characteristics of Delta (including biological features and clinical characteristics), analyze potential reasons for its strong transmission, and provide potential protective ways for combating Delta.
引用
收藏
页码:1844 / 1851
页数:8
相关论文
共 50 条
  • [1] Enhanced fitness of SARS-CoV-2 B.1.617.2 Delta variant in ferrets
    Sun, Xiangjie
    Belser, Jessica A.
    Kieran, Troy J.
    Brock, Nicole
    Pulit-Penaloza, Joanna A.
    Pappas, Claudia
    Thakur, Poulami Basu
    Jones, Joyce
    Wentworth, David E.
    Zhou, Bin
    Tumpey, Terrence M.
    Maines, Taronna R.
    [J]. VIROLOGY, 2023, 582 : 57 - 61
  • [2] SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
    Mlcochova, Petra
    Kemp, Steven A.
    Dhar, Mahesh Shanker
    Papa, Guido
    Meng, Bo
    Ferreira, Isabella A. T. M.
    Datir, Rawlings
    Collier, Dami A.
    Albecka, Anna
    Singh, Sujeet
    Pandey, Rajesh
    Brown, Jonathan
    Zhou, Jie
    Goonawardane, Niluka
    Mishra, Swapnil
    Whittaker, Charles
    Mellan, Thomas
    Marwal, Robin
    Datta, Meena
    Sengupta, Shantanu
    Ponnusamy, Kalaiarasan
    Radhakrishnan, Venkatraman Srinivasan
    Abdullahi, Adam
    Charles, Oscar
    Chattopadhyay, Partha
    Devi, Priti
    Caputo, Daniela
    Peacock, Tom
    Wattal, Chand
    Goel, Neeraj
    Satwik, Ambrish
    Vaishya, Raju
    Agarwal, Meenakshi
    Chauhan, Himanshu
    Chauhan, Himanshu
    Dikid, Tanzin
    Gogia, Hema
    Lall, Hemlata
    Verma, Kaptan
    Dhar, Mahesh Shanker
    Singh, Manoj K.
    Soni, Namita
    Meena, Namonarayan
    Madan, Preeti
    Singh, Priyanka
    Sharma, Ramesh
    Sharma, Rajeev
    Kabra, Sandhya
    Kumar, Sattender
    Kumari, Swati
    [J]. NATURE, 2021, 599 (7883) : 114 - +
  • [3] Charge transport properties of SARS-CoV-2 Delta variant (B.1.617.2)
    He, Lijun
    Xie, Zhiyang
    Long, Xing
    Zhang, Chaopeng
    He, Chengyun
    Zhao, Boyang
    Qi, Fei
    Zhang, Nan
    [J]. PROCESS BIOCHEMISTRY, 2022, 121 : 656 - 660
  • [4] SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
    Petra Mlcochova
    Steven A. Kemp
    Mahesh Shanker Dhar
    Guido Papa
    Bo Meng
    Isabella A. T. M. Ferreira
    Rawlings Datir
    Dami A. Collier
    Anna Albecka
    Sujeet Singh
    Rajesh Pandey
    Jonathan Brown
    Jie Zhou
    Niluka Goonawardane
    Swapnil Mishra
    Charles Whittaker
    Thomas Mellan
    Robin Marwal
    Meena Datta
    Shantanu Sengupta
    Kalaiarasan Ponnusamy
    Venkatraman Srinivasan Radhakrishnan
    Adam Abdullahi
    Oscar Charles
    Partha Chattopadhyay
    Priti Devi
    Daniela Caputo
    Tom Peacock
    Chand Wattal
    Neeraj Goel
    Ambrish Satwik
    Raju Vaishya
    Meenakshi Agarwal
    Antranik Mavousian
    Joo Hyeon Lee
    Jessica Bassi
    Chiara Silacci-Fegni
    Christian Saliba
    Dora Pinto
    Takashi Irie
    Isao Yoshida
    William L. Hamilton
    Kei Sato
    Samir Bhatt
    Seth Flaxman
    Leo C. James
    Davide Corti
    Luca Piccoli
    Wendy S. Barclay
    Partha Rakshit
    [J]. Nature, 2021, 599 : 114 - 119
  • [5] SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
    Israeli, Eitan
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2021, 23 (11): : 689 - 689
  • [6] Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant
    Rosato, Adriana E.
    Msiha, Engy
    Weng, Bruce
    Mesisca, Michael
    Gnass, Ronaldo
    Gnass, Silvia
    Bol, Cedric
    Tabuenca, Arnold
    Rosato, Roberto R.
    [J]. PATHOLOGY, 2022, 54 (03) : 351 - 356
  • [7] Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2
    Chun, June Young
    Jeong, Hwichang
    Kim, Yongdai
    [J]. JAMA NETWORK OPEN, 2022, 5 (03)
  • [8] Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals
    Caserta, Leonardo C.
    Martins, Mathias
    Cronk, Brittany
    Anderson, Renee
    Eldridge, Harry
    Gallow, Deidre
    Kruppa, Frank
    Plocharczyk, Elizabeth
    Diel, Diego G.
    [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [9] Serial intervals in SARS-CoV-2 B.1.617.2 variant cases
    Pung, Rachael
    Mak, Tze Minn
    Kucharski, Adam J.
    Lee, Vernon J.
    [J]. LANCET, 2021, 398 (10303): : 837 - 838
  • [10] Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
    Dhawan, Manish
    Sharma, Abhilasha
    Priyanka
    Thakur, Nanamika
    Rajkhowa, Tridib Kumar
    Choudhary, Om Prakash
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)